AIM ImmunoTech Inc. · AMEX:AIM

Equels Thomas K bought 50,000 AIM ImmunoTech Inc. shares (Form 4)

Traded Nov 19, 2026 · Filed Nov 20, 2026

On Nov 19, 2026, Equels Thomas K (Director, CEO & President) bought 50,000 AIM ImmunoTech Inc. shares at US$0.13 for US$6,550, leaving 436,095 shares. Filed Nov 20, 2026 (Form 4).

Bought
50,000 shares
Price
US$0.13
Value
US$6,550
Holding after
436,095 shares
Trading plan
No
Role
Director, CEO & President

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 19, 2026Common StockBuy50,000US$0.13436,095Direct

Source

Download original · View original at SEC

Related